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Background: Superparamagnetic iron oxide nanoparticles (IONPs) have been used as magnetic resonance imaging
contrast agents for various research and diagnostic purposes, such as the detection of neuroinflammation and
blood-brain-barrier integrity. As the central resident macrophage-like cells, microglia are responsible for managing
foreign agents invading the CNS. The present study investigated the direct effect of IONPs on the production of
pro-inflammatory cytokines by murine microglia stimulated with lipopolysaccharide (LPS).
Methods: Primary murine microglial cells were pretreated with IONPs (1–50 μg Fe/mL) for 30 min and then
stimulated with LPS (100 ng/mL) for 24 h. Confocal microscopy is used to visualize the intracellular IONP
distribution and secretory lysosomes after staining with LysoTracker and Rab27a, respectively. The production of
interleukin (IL)-1β and tumor necrosis factor (TNF)-α was quantified by ELISA. The activity of IL-1β converting
enzyme (ICE) and TNF-α converting enzyme (TACE) was measured by fluorescent microplate assay using specific
substrates. The lysosomal number, alkalinity, permeability and cathepsin B activity were determined by flow
cytometry with ectodermal dysplasia-1, lysosensor and acridine orange staining, and using cathepsin B specific
substrate, respectively.
Results: Confocal imaging revealed that IONPs were markedly engulfed by microglia. Exposure to IONPs attenuated
the production of IL-1β, but not TNF-α. Concordantly, the activity of ICE, but not the TACE, was suppressed in IONP-
treated cells. Mechanistic studies showed that IONPs accumulated in lysosomes and the number of lysosomes was
increased in IONP-treated cells. In addition, exposure to IONPs increased lysosomal permeability and alkalinity, but
decreased the activity of cathepsin B, a secretory lysosomal enzyme involved in the activation of ICE.
Conclusions: Our results demonstrated a contrasting effect of IONPs on the production of IL-1β and TNF-α by
LPS-stimulated microglia, in which the attenuation of IL-1β by IONPs was mediated by inhibiting the secretory
lysosomal pathway of cytokine processing.
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Iron oxide nanoparticles (IONPs) have been employed
for a variety of biomedical research and diagnostic pur-
poses, including cancer treatment, cell labeling, drug
delivery and magnetic resonance imaging (MRI) [1-4].
Previous studies reported that IONPs affected the viability
and functionality of macrophages, including the induction
of oxidative stress and apoptosis, and the suppression of
phagocytic activity and cytokine production [5-9]. In
addition, IONPs have been shown capable of crossing the
blood-brain-barrier, rendering IONPs a promising imaging
agent for the diagnosis of neuroinflammation and brain
injury [10-12]. In light of the increasingly applications of
IONPs for the diagnostic imaging of the central nervous
system (CNS), the interaction between brain cells and
IONPs is a relevant issue to be addressed. To date, it re-
mains mostly elusive if IONPs influence the functionality
of central immune cells, such as microglia.
Microglia are the brain-resident macrophage-like im-
munocompetent cells responsible for the surveillance of
homeostasis in the CNS. In response to pathogen infec-
tion, foreign agent invasion and injury, microglia are
rapidly activated, and undergo morphologic and func-
tional alterations, including proliferation, migration to
the site of inflammation, and phagocytosis of foreign
agents and cell debris. In addition, activated microglia
produce pro-inflammatory cytokines and cytotoxic fac-
tors, including interleukin (IL)-1β, nitric oxide (NO),
tumor necrosis factor (TNF)-α and reactive oxygen spe-
cies (ROS) [13,14]. These mediators play a key role in
the prevention of brain cells from further damage and to
promote the repair of the damaged tissue. For example,
IL-1β produced by activated microglia enhances the
proliferation of astrocytes, stimulates neovascularization
and promotes the repair of nervous tissues [15-18].
Microglial TNF-α can promote neural cell survival and
proliferation, and enhance the release of glutamate from
astrocytes [19,20]. Previous studies reported that intra-
nasal administration of gold nanoparticles to mice in-
duced microglial activation and internalization of gold
nanoparticles, and a transient up-regulation of Toll-like
receptor-2 in the olfactory bulb [21]. In addition, intra-
nasal exposure of mice to IONPs resulted in the trans-
portation of the nanoparticles into the brain via the
olfactory route, and induced the recruitment, activation
and proliferation of microglia cells in the brain. Expos-
ure of BV2 microglial cells to IONPs elicited a marked
production of ROS and NO. IONPs were also found to
be engulfed by BV2 cells, which induced a large number
of cellular vesicles, swelling of endoplasmic reticulum
and morphological alterations of mitochondrial cristae
[22]. Collectively, these results indicate that the func-
tionality and morphology of resting microglia are altered
in response to nanoparticle exposure. Microglia play apivotal role in neuroinflammation, in which they can be
activated by various stimuli, such as lipopolysaccharides
(LPS) derived from Gram-negative bacteria. To date, evi-
dence pertaining to the potential impact of IONPs on
the functionality of activated microglia is scarce. The ob-
jective of the present study was to investigate the effect
of IONPs on the expression of pro-inflammatory cyto-
kines by LPS-activated microglia. Here, we reported that
IONPs suppressed the production of IL-1β by activated
microglia via the secretory lysosomal pathway of cyto-
kine processing.
Results and discussion
Characterization of IONPs and uptake of IONPs by
primary microglia
The present study employed the commercial prepar-
ation of carboxydextran-coated IONPs ResovistW that
has been used in clinical as an imaging contrasting
agent. The crystalline core of ResovistW is composed of
magnetite (Fe3O4) and maghemite (Fe2O3). According
to the package insert of ResovistW, the hydrodynamic di-
ameters of the nanoparticles range between 45–60 nm.
Our confirmatory experiments revealed that ResovistW
exhibited a monodisperse population of particles with
an average diameter of 58.7 nm in saline [23]. The zeta
potentials of the particles in saline and in the culture
medium were −13.9 mV and −9.01 mV, respectively.
IONPs in culture medium remained a similar net
negative-charge as in the serum-free saline. Primary
microglial cells were pretreated with IONPs (1–50 μg
Fe/mL), and then stimulated with LPS (100 ng/mL) for
24 h. Confocal microscopy was used to monitor the
uptake of IONPs, and the images showed the accumula-
tion of dark brown dots in the cytoplasm of cells ex-
posed to IONPs (Figure 1A). These results confirmed
the uptake of IONPs by phagocytic cells [9,24-26].
IONPs did not affect the viability of primary microglia
Although IONPs are generally considered biocompatible,
high concentrations of IONPs have been reported to
cause cytotoxicity in several glial lines [27]. Moreover,
IONPs induced the disappearance of mitochondrial cris-
tae and swelling of endoplasmic reticulum (ER) in BV2
microglial cells [22]. Five-day exposure to IONPs elicited
ROS-mediated apoptosis in human macrophages [6].
Other metal nanoparticles such as titanium dioxide also in-
duced apoptosis in murine N9 microglial cells [28]. It is cur-
rently unclear whether IONPs affect the viability of primary
microglia. Hence, the cell viability was measured using the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium brom-
ide (MTT) assay. Exposure to IONPs (1–50 μg Fe/mL) for
24 h did not affect cell viability compared to the LPS-
stimulated control group (Figure 1B), and the morph-
ology of cells appeared unchanged (Figure 1A). These
Figure 1 Exposure to iron oxide nanoparticles (IONPs) did not cause cytotoxicity to primary microglial cells. Primary microglial cells
(4 × 105 cells/mL) were either left untreated (naïve; NA), or pretreated with IONPs (1–50 μg Fe/mL) for 30 min followed by stimulation with LPS
(100 ng/mL) for 24 h. (A) The nuclei of cells pretreated with IONPs and stimulated with LPS were visualized by confocal microscopy with Hoechst
(blue) staining. In the bright field, cells treated with IONPs show numerous dark brown dots accumulated intracellularly. (B) The cell viability was
determined by the MTT assay. Data are expressed as the mean ± SE of triplicate cultures. Results are a representative of three
independent experiments.
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exposure of macrophages to carboxydextran-coated IONPs
induced no cytotoxicity [6,9,29].
IONPs differentially modulated the production of
proinflammatory cytokines by LPS-stimulated microglia
To address the potential impact of IONPs on the func-
tionality of activated microglia, we examined the produc-
tion of IL-1β and TNF-α by LPS-stimulated microglia.
Exposure to IONPs significantly attenuated the produc-
tion of IL-1β, but not TNF-α (Figure 2A and 2B). The
maturation of IL-1β and TNF-α requires the proteolytic
cleavage of pro-IL-1β and pro-TNF-α by IL-1β converting
enzyme (ICE; caspase-1) and TNF-α converting enzyme
(TACE), respectively [30,31]. Hence, the activity of these
two enzymes was measured using specific fluorescent sub-
strates. Consistent with the differential effect on cytokine
production, exposure to IONPs (50 μg/mL) significantly
attenuated the activity of ICE, but not TACE (Figure 2C
and 2D). These results provide the first evidence to
show that direct exposure to IONPs differentially modu-
lated the production of IL-1β and TNF-α by LPS-
stimulated microglia.
Cytokines can be processed via the classical or non-
classical secretory pathway. In particular, TNF-α is re-
leased through the classical pathway, in which newly
synthesized pro-TNF-α was trafficked from the ER
through the Golgi to recycling endosomes, which fused
with cell membrane for the cleavage of pro-TNF-α by
TACE and then exocytotic release of mature TNF-α
[32,33]. In contrast to the processing of TNF-α, IL-1βlacks the N-terminal signal sequence required for ER
entry and thus is released through the non-classical
pathway independent of ER/Golgi trafficking [34]. Sev-
eral mechanisms associated with the release of IL-1β
have been proposed, including the exocytosis of IL-1β
containing secretory lysosomes, shedding of plasma
membrane microvesicles, release of IL-1β exosomes
from multivesicular bodies and export of IL-1β through
ATP-binding cassette transporters [35,36]. Previous
studies showed that silica-based nanoparticles inhibited
the mRNA expression of TNF-α by microglia [37].
Interestingly, our data revealed that exposure of LPS-
stimulated microglia to IONPs inhibited ICE activity
and IL-1β secretion, whereas TACE and TNF-α were
unaltered (Figure 2), indicating that the non-classical
secretory pathway, rather than the ER/Golgi classical
secretory pathway, was affected by IONPs.
IONPs located in lysosomes and increased the number of
lysosomes
Previous studies reported the accumulation of IONPs in
lysosomes of macrophages [38]. Gold nanoparticles also
accumulated in lysosomes of N9 microglial cells [21],
implicating that lysosomes may be a critical intracellular
target for nanoparticles in phagocytic cells. In addition,
it has been shown that the lysosomal enzyme cathepsin
B plays a key role in the processing and maturation of
IL-1β in activated microglia [39]. To elucidate the
underlying mechanisms for IONP-mediated differential
effects on the production of IL-1β and TNF-α, the
functionality of lysosomes was studied. The intracellular
Figure 2 IONPs differentially affected the production of IL-1β and TNF-α, and the activity of ICE and TACE in LPS-stimulated microglia.
Primary microglial cells (4 × 105 cells/mL) were either left untreated (naïve; NA), or pretreated with IONPs (1–50 μg Fe/mL) for 30 min followed by
stimulation with LPS (100 ng/mL) for 24 h. (A and B) The level of IL-1β and TNF-α in the supernatants was measured by ELISA. (C and D) The cell
lysates were incubated with fluorogenic ICE or TACE substrates for 1 h at 37°C. The fluorescence of cleaved substrates was detected using a
fluorescent microplate reader. Data are expressed as the mean ± SE of triplicate cultures. N.D., the level of IL-1β and TNF-α was below the limit of
detection. * p < 0.05 compared to the LPS group. Results are a representative of three independent experiments. MFI, mean fluorescence intensity.
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copy using the lysosomal marker LysoTracker™ Red DND-
99. We revealed that many of dark brown dots in the
cytoplasm were colocalized with the red fluorescence of
LysoTracker™, demonstrating the distribution of IONPs in
lysosomes (Figure 3A). We also observed that some lyso-
somes did not contain nanoparticle dots, and that some
internalized IONPs did not colocalize with lysosomes
(Figure 3A). Hence, not all IONPs were located in lyso-
somes. Previous results showed that IONPs could be
endocytosed by macrophages and microglia [22,38,40,41].
We therefore speculate that IONPs may distribute in cyto-
plasmic compartments other than lysosomes, such as
endosomes, which may account for the observed non-
lysosomal distribution of IONPs. Next, we investigated the
effect of IONPs on the number of lysosomes by measuring
the expression of the macrophage/microglia specific lyso-
somal membrane protein ectodermal dysplasia (ED)-1. Ex-
posure to IONPs markedly increased the expression of
ED-1 (Figure 3B), indicating that the number of lyso-
somes was increased. Our results are in agreement withprevious results showing that intranasal exposure of
mice to IONPs resulted in an increased number of lyso-
somes in microglia [22].
IONPs attenuated the activity of cathepsin B
Secretory lysosomes serve both as a degradative and as
a secretory compartment. To date, most cell types
containing secretory lysosomes are hematopoietic lineage-
derived immunocytes, including dendritic cells, lympho-
cytes, macrophages, etc. [42,43]. It remains unclear if
microglia possess secretory lysosomes. The secretory
lysosomes were examined by determining the expression
of Rab27a, a small GTPase involved in the fusion of
secretory lysosomes with plasma membrane during the
final stage of cytokine exocytosis [43,44]. In addition to
lysosomal exocytosis, Rab27a has been associated with
exosome secretion [45]. As shown in Figure 4A, the merge
image of LPS-stimulated microglia showed a diffuse distri-
bution of orange signals, demonstrating the colocalization
of cathepsin B and Rab27a. Notably, very few red (cathepsin
B-single positive) signals were observed in the merged
Figure 3 IONPs located in lysosomes and increased the number of lysosomes in LPS-stimulated microglia. Primary microglial cells
(4 × 105 cells/mL) were either left untreated (naïve; NA), or pretreated with IONPs (1–50 μg Fe/mL) for 30 min followed by stimulation with LPS
(100 ng/mL) for 24 h. (A) The lysosomes of cells were visualized by confocal microscopy with LysoTracker (red) staining. Cells treated with IONPs
show an extensive distribution of the internalized dark brown dots of IONPs. Arrows indicate the colocalization of some dark brown spots and
lysosomes. (B) The expression of ED-1 was measured by flow cytometry. Data are expressed as the mean ± SE of triplicate cultures. Results are a
representative of three independent experiments. * p < 0.05 compared to the LPS group. MFI, mean fluorescence intensity.
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in Rab27a-positive sites. As cathepsin B is a critical lyso-
somal protease [46,47], these results suggest that the
colocalization signals primarily represent secretory lyso-
somes, rather than exosomes. We also observed some
green (Rab27a-single positive) signals in the merged
image, demonstrating that some of Rab27a-positive siteswere not lysosomes, which might be exosomes. Further
studies are required to address this notion. We further
observed that exposure to IONPs markedly attenuated
red (cathepsin B-single positive) and the merged orange
signals (Figure 4A). Quantitative data from flow cytom-
etry confirmed that exposure to IONPs (10–50 μg Fe/
mL) significantly attenuated the cathepsin B activity
Figure 4 IONPs attenuated the cathepsin B enzyme activity of secretory lysosomes in LPS-stimulated microglia. Primary microglial cells
(4 × 105 cells/mL) were either left untreated (naïve; NA), or pretreated with IONPs (1–50 μg Fe/mL) for 30 min followed by stimulation with LPS
(100 ng/mL) for 24 h. (A) The cells pretreated with IONPs and stimulated with LPS were incubated with the cathepsin B substrate (red) for 1 h at
37°C and then stained for the secretory lysosome marker Rab27a (green). The fluorescence was visualized by confocal microscopy. Note the
presence of orange signals in the merged images indicating the colocalization of cathepsin B and Rab27a. (B) The red fluorescence of 5000
single cells was measured by flow cytometry. Data are expressed as the mean ± SE of triplicate cultures. Results are a representative of three
independent experiments. * p < 0.05 compared to the control group. MFI, mean fluorescence intensity.
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IONPs attenuated the cathepsin B activity in the secretory
lysosomes of microglia. As cathepsin B is involved in the
processing of IL-1β in activated microglia [39], we specu-
late that IONPs may affect the secretory lysosomal path-
way of IL-1β processing.IONPs elevated lysosomal alkalinity and permeability
The acid environment in lysosomes is crucial for the
optimal function of lysosomal enzymes [48]. The acidity
of lysosomes was measured by flow cytometry using
LysoSensor Green DND-189, which emits fluorescence in
acidic organelles, such as lysosomes [49]. The fluorescent
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IONP-treated cells (Figure 5A and 5B), indicating an in-
creased pH in lysosomes. We next examined whether
IONPs affected the permeability of lysosomes using acrid-
ine orange that can be trapped in lysosomes and emits red
fluorescence. Exposure of microglia to IONPs attenuated
acridine orange fluorescence (Figure 5C and 5D), indicat-
ing an increased lysosomal permeability. Collectively,
these results suggest that exposure to IONPs might impair
lysosomal functions by increasing the lysosomal perme-
ability and alkalinity in LPS-stimulated microglia. Our
findings are in line with previous results showing that gold
nanoparticles impair lysosomal degradation by elevating
the lysosomal alkalinity in rat normal kidney cells [49].
Moreover, the disruption of lysosomal integrity could be a
critical mechanism contributing to IONP-mediated sup-
pression of the secretory lysosomal processing of IL-1β
production in LPS-stimulated microglia.Figure 5 IONPs increased the alkalinity and permeability of lysosome
mL) were either left untreated (naïve; NA), or pretreated with IONPs (1–50
24 h. (A and B) The acidity of lysosomes was evaluated by flow cytometry
of microglial cells were measured by flow cytometry with acridine orange
acridine orange in cells pretreated with IONPs (50 μg Fe/mL) and stimulate
triplicate cultures. Results are a representative of three independent experim
fluorescence intensity.IL-1β is one of the major pro-inflammatory cytokine
produced by activated microglia, which induces the pro-
duction of IL-6 and NO in astrocytes [16,17], and in-
crease oxidative activity in microglia [50]. In addition,
IL-1β released by microglia induces the proliferation of
astrocytes, stimulates neovascularization and promotes
repair of the CNS in brain injury [15,18]. In the present
study, we showed that IONPs attenuated IL-1β produc-
tion by suppressing the secretory lysosomal functionality
in LPS-stimulated microglia. These results suggest that
IONPs might impair the host defense against pathogens
and the repairing capacity in the CNS. In addition, micro-
glia are the major immunocompetent cells possessing
antigen-presenting functions in the CNS [16]. It has been
shown that lysosomal cysteine proteases, including ca-
thepsin B, are involved in the regulation of antigen pro-
cessing in APC [51]. Our data showing the suppression of
cathepsin B activity by IONPs suggest that the microglials in LPS-stimulated microglia. Primary microglial cells (4 × 105 cells/
μg Fe/mL) for 30 min followed by stimulation with LPS (100 ng/mL) for
with lysosensor Green DND-189 staining. (C and D) The permeability
staining. (B and D) Representative histograms of lysosensor and
d with LPS were shown. Data are expressed as the mean ± SE of
ents. * p < 0.05 compared to the LPS group. MFI, mean
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ther studies are warranted to address this issue.
Conclusions
The present study showed that IONPs accumulated in
lysosomes and suppressed the production of IL-1β by
affecting the secretory lysosomal pathway of cytokine
processing in LPS-stimulated microglia. These findings
provide new insights to the potential impact of IONP
exposure on the functionality of activated microglia and
indicate lysosomes as a crucial intracellular target for
IONPs. Together with previous reports showing various
effects on microglial functionality by other nanoparticles,
including gold, silica, and titanium oxide [21,37,49,52],
exposure to nanoparticles may cause microglial dysfunc-




All reagents were purchased from Sigma Chemical
(St Louis, MO) unless otherwise stated. ResovistW, a
commercial preparation of carboxydextran-coated iron
oxide nanoparticles (IONPs) containing 28 mg Fe/mL,
was obtained from Schering AG (Berlin, Germany).
Dulbecco’s Modified Eagle Medium (DMEM) was ob-
tained from Caisson Laboratories (Rexburg, ID). Fetal
bovine serum (FBS), horse serum (HS) and cell culture re-
agents were purchased from GIBCO BRL (Gaithersburg,
MD). Enzyme-linked immunosorbent assay (ELISA) sets
for cytokine measurement were purchased from BD
Biosciences (San Diego, CA). ICE/Caspase 1 protease
assay kit and fluorogenic substrates Ac-YVAD-AFC
(7-amino-4-methylcoumarin) were obtained from Chemicon
(Temecula, CA) and Tocris (Bristol, UK), respectively.
TACE fluorogenic activity assay kit was purchased from
AnaSpec (San Jose, CA). Magic Red™ cathepsin B detec-
tion kit was purchased from Immunochemistry Technolo-
gies (Bloomington, MN).
Culture of primary murine microglial cells
Primary mix glial cultures were prepared as previously
described with minor modifications [53]. Briefly, after
decapitation, forebrains of new-born BALB/c mice were
dissociated mechanically. Their meninges were removed
aseptically and the brain cells were resuspended in
DMEM containing 10% FBS, 10% HS, 4 mM L-glutam-
ine, 100 U/mL penicillin and 100 μg/mL streptomycin.
The cells were cultured on poly-D-lysine (25 μg/mL)-
coated flasks, and medium was replenished 6–8 days
after initial seeding. Upon reaching confluence (12−16
days), loosely adherent microglial cells were collected by
shaking at 165 rpm at 37°C for 3 h. The enriched micro-
glial cells were cultured on culture plates for 2 h to allowattachment, and then the medium was changed to DMEM
containing 1% HS, 4 mM L-glutamine, 100 U/mL penicillin
and 100 μg/mL streptomycin for experiments with IONPs
exposure. In all cases, the cells were cultured at 37°C in 5%
CO2. The purity of microglial culture was > 90% as deter-
mined by flow cytometry with CD11b staining.
Characterization of IONPs
The particle size distribution and zeta potential of the
IONPs were measured by phase analysis light scattering
using Zetasizer nano-ZS (Malvern Instruments Ltd,
Malvern, Worcestershire, UK). IONPs were appropriately
diluted with 0.22 μm-filtered saline for size measurement
at 25°C. The zeta potentials of IONPs in saline and culture
medium (DMEM containing 1% horse serum) were mea-
sured at 25°C.
Confocal imaging of engulfed nanoparticles and
lysosomes
Microglial cells (4 × 105 cells/mL) cultured on cover slips
were pretreated with IONPs (1–50 μg Fe/mL) for 30 min
followed by stimulation with LPS (100 ng/mL; Escherichia
coli O55:B5) for 24 h. The cells were stained with 1 μM
LysoTracker™ Red DND-99 (Invitrogen, Carlsbad, CA) for
2 h at 37°C. After washing, the cells were fixed with 4%
paraformaldehyde for 15 min at room temperature. For
detection of nuclei, the fixed cells were stained with
Hoechst 33258 (5 μg/mL) at room temperature for 5 min.
After washing, the cells were mounted in ProLong Gold
antifade reagent (Invitrogen, Carlsbad, CA) and visualized
on a Leica TCS SP5 II scanning confocal microscope
(Leica Microsystems, Wetzlar, Germany).
Measurement of cell viability
The viability of microglia was determined by the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide
(MTT) assay. Microglial cells (4 × 105 cells/mL) were
cultured in quadruplicate in a 96-well plate (0.1 mL/
well). The cells were either left untreated (naïve; NA),
or pretreated with IONPs (1–50 μg Fe/mL) for 30 min
followed by stimulation with LPS (100 ng/mL) for 24 h.
An MTT stock solution (5 mg/mL) was added to each
well (10 μL/well) 4 h before the end of incubation. After
washing, the formed formazan was dissolved by the
addition of lysis buffer (10% SDS in N,N-dimethyl-
formamide; 200 μL/well). The absorbance of the formazan
product was measured at 570 nm and at 630 nm as a
background reference, using a microplate reader
(Dynatech Laboratories, Chantilly, VA).
Measurement of cytokines
Microglial cells (4 × 105 cells/mL) were cultured in
tripricate in a 48-well plate (0.25 mL/well) and treated
with IONPs and LPS as described above in the MTT
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for IL-1β and TNF-α by standard sandwich ELISA.
Measurement of ICE and TACE activity
Microglial cells (4 × 105 cells/mL) were cultured in a 6-cm
dish (5.5 mL/dish) and treated with IONPs and LPS as de-
scribed above in the MTT assay. After washing, the cells
were harvested and lysed with cell lysis buffer. The lysates
were incubated with 200 μM of the ICE fluorogenic sub-
strates Ac-YVAD-AFC and 5 mM of DTT for 1 h at 37°C,
and the fluorescence was measured at 400 nm excitation
and 505 nm emissions. The cell lysates were also incu-
bated with 40 μM of the TACE fluorogenic substrate for 1
h at 37°C in the dark with gentle shaking, and the fluores-
cence was detected at 490 nm excitation and 520 nm
emissions.
Analysis of the amount of lysosomes
Microglial cells (4 × 105 cells/mL) were cultured in
tripricate in a 24-well plate (0.5 mL/well) and treated with
IONPs and LPS as described above in the MTT assay. The
cells were fixed in 4% paraformaldehyde, permeabilized
with 0.2% Trion-X and incubated in blocking buffer
containing 2.5% BSA in PBS for 30 min at 4°C. The cells
were then stained with appropriately diluted APC-labeled
rat anti-mouse ED-1 antibody (BioLegend, CA) for 1 h at
4°C in the dark. After washing, the fluorescence of 5000
single cells for each sample was measured using a flow
cytometer at emission of 670 nm (BD LSRFortessa, San
Jose, CA). The data were analyzed using the software
Flowjo 5.7.
Measurement of lysosomal acidity and permeability
The acidity and permeability of lysosome were determined
by flow cytometry using LysoSensor™ Green DND-189
and acridine orange, respectively. Microglial cells (4 × 105
cells/mL) were cultured in tripricate in a 48-well plate
(0.25 mL/well) and treated with IONPs and LPS as de-
scribed above in the MTT saasy. The cells were stained
with 1 μM Lysosensor™ for 2 h or 5 μg/mL acridine or-
ange for 10 min at 37°C. After washing, the fluorescence
of 5000 single cells for each sample was measured using a
flow cytometer at emission of 525 nm and 610 nm for
Lysosensor™ and acridine orange, respectively.
Detection of cathepsin B enzyme activity and secretory
lysosomes
Microglial cells (4 × 105 cells/mL) were cultured in
tripricate in a 48-well plate (0.25 mL/well) and treated
with IONPs and LPS as described above in the MTT
assay. The cells were stained with Magic Red™ cathepsin
B substrate for 1 h at 37°C. Once the substrate is cleaved
by active cathepsin B, its product emits red fluorescence
whose intensity is a direct measurement of the enzymaticactivity of cathepsin B. After washing, the fluorescence of
5000 single cells for each sample was measured using a
flow cytometer at emission of 610 nm and visualized on
a Leica TCS SP5 II scanning confocal microscope. The
secretory lysosomes in microglia were stained with ap-
propriately diluted Alexa Fluor 488-labeled rabbit anti-
Rab27a antibody (Bioss, MA) and visualized by confocal
microscopy as described above for ED-1 staining.
Statistical analysis
The mean ± standard error (SE) was determined for each
treatment group in the individual experiments. Homoge-
neous data were evaluated by a parametric analysis of vari-
ance, and Dunnett’s two-tailed t-test was used to compare
treatment groups to the control group. P value < 0.05 was
defined as statistical significance.
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